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Objectives: To investigate changing nutritional demographics of treated HIV-1-infected
patients and explore causes of obesity, particularly in women of African origin.
Methods: We prospectively reviewed nutritional demographics of clinic attenders at an
urban European HIV clinic during four one-month periods at three-yearly intervals (2001,
2004, 2007, and 2010) and in two consecutive whole-year reviews (2010–2011 and 2011–
2012). Risk-factors for obesity were assessed by multiple linear regression. A sub-study
of 50 HIV-positive African female patients investigated body-size/shape perception using
numerical, verbal, and pictorial cues.
Results:We found a dramatic rise in the prevalence of obesity (BMI>30 kg/m2), from 8.5
(2001) to 28% (2011–2012) for all clinic attenders, of whom 86% were on antiretroviral
treatment. Women of African origin were most affected, 49% being obese, with a further
32% overweight (BMI 25–30 kg/m2) in 2012. Clinical factors strongly associated with obe-
sity included female gender, black African ethnicity, non-smoking, age, and CD4 count (all
P <0.001); greater duration of cART did not predict obesity. Individual weight-time trends
mostly showed slow long-term progressive weight gain. Investigating body-weight per-
ception, we found that weight and adiposity were underestimated by obese subjects, who
showed a greater disparity between perceived and actual adiposity (P <0.001). Obese sub-
jects targeted more obese target “ideal” body shapes (P <0.01), but were less satisfied
with their body shape overall (P =0.02).
Conclusion: Seropositive African women on antiretroviral treatment are at heightened risk
of obesity. Although multifactorial, body-weight perception represents a potential target
for intervention.
Keywords: HIV, body weight, body mass index, obesity, antiretroviral treatment, ethnology, HIV-associated
lipodystrophy syndrome
INTRODUCTION
When the HIV/AIDS pandemic emerged in the 1980’s wasting
represented the major metabolic consequence of the disease (1)
and was recognized as an AIDS-defining criterion. The revolu-
tion in HIV care resulting from the introduction of combination
antiretroviral treatment (cART) has been matched by dramatic
improvements in nutritional status (2), although wasting remains
problematic in some settings (3). Early treatment regimes were,
however, associated with other metabolic sequelae, most notably
HIV-associated lipodystrophy syndrome (HALS). The visceral adi-
posity associated with HALS is of particular concern because of
its association with insulin resistance, diabetes, and cardiovascu-
lar disease, effects which may be compounded by the effects of
cART itself (4, 5). The prevalence of HALS has declined markedly
in recent years with changing patterns of drug use (6) but has
been replaced by today’s emerging metabolic problem, obesity
(7–9). Obesity, which represents an entity distinct from visceral
lipodystrophy (10), has recently been reported in several HIV-
positive cohorts (2, 7, 8, 11, 12). There is evidence that black
African ethnicity and female gender increase the risk of weight
gain on cART (2, 11, 13, 14), although most studies regarding
African ethnicity have focused on African-American populations
(15, 16).
If the enhanced risk of obesity among HIV-infected women
of African origin is a real effect, several plausible mechanisms
might be proposed. First, genetics are clearly pivotal (17, 18).
BMI has been linked to specific chromosomal loci in two separate
African-American populations (19) and resistin gene polymor-
phisms contribute to hyperlipidemia and insulin-resistance on
cART (20). Polymorphisms in uncoupling proteins are linked to
ethnicity (21, 22) and, specifically, variants of uncoupling protein-
3 with reduced basal metabolism in African-American women
(23). Second, physiological adaptations occur with migration
or environmental and dietary changes; adaptations to early-life
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limited nutrition may constitute maladaptations to later-life nutri-
tional abundance (24, 25). More acute physiological adaptations
occur with wasting syndromes; typically, on recovery an “over-
shoot” occurs with preferential recovery of adipose and delayed
recovery of lean tissue in the early recovery phase, as demon-
strated both in post-starvation re-feeding (26) and recovery from
pulmonary tuberculosis (27).
Such genetic and physiologic determinants of body weight may,
however, be less relevant in clinical practice for two reasons; first,
they represent poor targets for intervention and, second, powerful
cultural and ethnic drivers for body-weight change are superim-
posed upon and may over-ride them. Body image is a key deter-
minant of “usual” weight and body-weight perception influences
food intake. Widely held dogma suggests that women of African
origin are likely to desire larger body sizes (28). Although evidence
for this tenet is largely anecdotal, several studies support it. For
example, Ugandan-born subjects in Britain rated heavier figures
more positively than British natives (29), and African-Americans
recorded greater satisfaction with body image and less anxiety
regarding weight than comparable white American women (30–
32). Such attitudes can also be found among HIV-infected women.
In one study, more seropositive African-Americans wished to be
“bigger” than did non-African-Americans (32 versus 15%) and
more overweight participants perceived themselves as of “normal”
weight (81 versus 50%) (28). Such views are not limited to urban
African-American communities. Qualitative studies in disadvan-
taged communities in South Africa found that increased body
size represented a marker of well-being (33); furthermore, two-
thirds of adolescent women associated fatness with happiness and
health (34). Not all authors endorse this simplistic paradigm; an
urban Los Angeles study found no evidence that ethnicity influ-
ences preference for body shape or tolerance of obesity (35). If
weight perception is a significant determinant, it represents a factor
potentially amenable to intervention.
This paper reports a series of studies aiming, first, to test
the hypothesis that obesity is an emerging clinical issue for
HIV-positive patients on treatment (2); second, to investigate
risk-factors for obesity in this population; and third, to explore
how body-weight and body-shape perception relate to nutritional
status and obesity among women of African origin.
MATERIALS AND METHODS
This study followed relevant institutional and national guidelines
and regulations with the agreement of the Local Research Ethics
Committee. The setting was a London (UK) tertiary-hospital HIV
clinic.
To assess whether obesity is an emerging clinical issue for
HIV-positive patients on treatment, clinical and nutritional demo-
graphic data were collected in two ways:
(i) Prospective one-month surveys, collecting nutritional and
basic demographic data, were performed on all adult (≥ 18y)
HIV-clinic attenders in the month of February every 3 years
from 2001 to 2010. [Some data have previously been pub-
lished (2).]
(ii) Two consecutive whole-year surveys were performed in 2010–
2011 (n= 1166) and 2011–2012 (n= 1031) in which extensive
clinical data, including nutritional data, were collected. The
data collection form was modified between the first and the
second one-year survey, so each survey was analyzed sepa-
rately. Repeat visits and pregnant patients (including ≤3-
months post-natal) were excluded. BMI was classified accord-
ing to WHO descriptors: <18.5, wasted; 18.5–20, under-
weight; 20–25, normal; 25–30, overweight;>30, obese (36). In
order to assess how obesity had arisen in those with the highest
BMI values, weight recordings were retrieved from the hos-
pital notes of 30 consecutive obese African women with ade-
quately complete records (representing >180 patient-years of
drug exposure). Trends were analyzed descriptively, as in anal-
ogous HIV-wasting studies (37), and by linear regression to
derive a rate of weight change per year.
To investigate the risk-factors for obesity, we analyzed the large
(n > 1000) 2010–2011 and 2011–2012 cohorts, relating BMI to
clinical parameters (listed below) by simple and multiple-stepwise
regression. Preceding one-month cohorts were not analyzed in this
way because of their smaller size. For a comparator “normal” pop-
ulation, we used the “Health Survey for England” data set, which
includes BMI data on 11,022 UK residents, 5,443 of whom are
classified by ethnicity (38).
The relationship between body-weight/shape perception and
obesity was assessed in 50 adult non-pregnant African women
using a structured questionnaire. Subjects were recruited con-
secutively from clinic attenders willing to participate, regard-
less of BMI (hence both obese and non-obese patients were
included). The questionnaire was produced in-house after pilot-
ing preliminary drafts and included questions on weight history,
treatment, perceived links between treatment and weight change,
background history (country of origin), ability to identify other
major cardiovascular risk factors (smoking, diabetes, hyperten-
sion, hypercholesterolemia, and family history of stroke/heart
disease), and level of satisfaction with current weight on a Likert
scale. Current perception of body shape/body weight was assessed
in three complementary ways: (1) numerically in kilograms: sub-
jects rated their “usual” and “ideal” weights (normalized to BMI
for between-subject comparisons); (2) textually: identifying their
current nutritional status in terms of WHO descriptors (“wasted,
underweight, normal, overweight, obese”); and (3) pictorially
using figural stimuli: subjects identified current and ideal body
shapes using images of known adiposity. Two published series of
silhouettes were used: one (Series A) consisted of seven silhou-
ettes corresponding to specified BMI’s; (39) the other (Series B),
nine silhouettes of increasing adiposity, not calibrated by BMI
(40). For body image scores, background comparator data were
derived from published cohorts of 16,728 Caucasians (41) and
389 American women of mixed ethnicity (42).
Analysis of potential causes of obesity was framed around five
putative hypotheses. Statistical comparisons were made by Fishers
exact test and linear regression using Prism (GraphPad Software
Inc., CA, USA) and Sigmaplot (Systat Software Inc., CA, USA).
RESULTS
TIME-TRENDS IN NUTRITIONAL DEMOGRAPHICS
One-month clinic datasets for nutritional demographics included
164, 204, 196, and 373 subjects in 2001, 2004, 2007, and 2010
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respectively. Time-trends in BMI clearly showed an increasing
prevalence of obesity over this period (Figure 1). This trend
was most marked in women of black African descent; when each
demographic group was considered separately (Figure S1 in Sup-
plementary Material) this was the group most affected. In 2001,
only 20% of black African women were obese, but this value
increased progressively with each prospective three-yearly review,
reaching 49% in 2012, a 2.5-fold increase in the prevalence of obe-
sity over 10 years (Figure 1B). Male obesity also increased over the
same time period, from 2 to 13%, although resulting levels of obe-
sity were less marked (Figure 1A). This observation was not due to
major changes in the overall demographics of patients attending
the clinic (Figure S2 in Supplementary Material).
Individual weight-time graphs for obese African women, all of
whom were on cART, revealed several distinct patterns (Figure
S3 in Supplementary Material). The dominant pattern was one
of slow progressive weight gain over several years (12/30); oth-
ers showed early weight gain followed by stabilization (9/30),
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FIGURE 1 | Changing nutritional status of HIV-clinic attenders
according to ethnicity and gender. Values represent number of
participants by gender [males (A) and females (B)], ethnicity (filled
columns, Asian; shaded columns, black African; open columns, white
Caucasian), and by BMI category: wasted (<18.5), undernourished
(18.5–20), normal (20–25), overweight (25–30), and obese (>30 kg/m2).
Data from 2001 to 2010 represent one-month prospective reviews, 2001
(n=164; 96:68 male:female), 2004 (n=204; 114:90), 2007 (n=196;
109:87), and 2010 (n=373; 213:160). Data from 2012 represent attenders
over a whole year (n= 1031); similar data were obtained in 2011 (not
shown). The small number of subjects in other ethnic groups is not shown
for clarity.
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Table 1 |Weight trends of obese African women on cART by drug-class.
Subject
reference
NNRTI
exposure
(year)
Cumulative
NNRTI effect
(kg/m2)
NNRTI trend
(kg/m2 year)
PI exposure
(year)
Cumulative
PI effect
(kg/m2)
PI trend
(kg/m2 year)
1 1.94 7.96 4.10 5.50 4.10 0.74
2 0.00 4.51 2.29 0.51
3 1.88 1.85 0.98 0.00
4 0.00 5.32 1.08 0.20
5 15.24 3.48 0.23 1.11 2.80 2.52
6 0.00 2.63 2.80 1.06
7 2.33 −0.29 −0.13 0.00
8 2.93 1.60 0.55 9.11 2.15 0.24
9 0.82 5.19 6.31 4.04 4.55 1.13
10 11.15 4.61 0.41 1.57 1.88 1.19
11 2.70 1.53 0.57 7.10 2.41 0.34
12 3.42 0.53 0.16 0.00
13 5.86 −0.35 −0.06 0.00
14 6.58 1.20 0.18 0.00
15 7.21 3.64 0.50 0.00
16 5.21 5.54 1.06 0.00
17 0.90 2.55 2.83 1.33 2.54 1.92
18 1.50 2.65 1.76 0.00
19 11.16 3.05 0.27 0.00
20 13.02 4.21 0.32 0.00
21 8.93 7.64 0.86 0.00
22* 5.64 4.11 0.73 0.00
23 1.11 0.11 0.10 0.00
24 0.00 2.99 3.29 1.10
25 1.42 3.26 2.29 15.12 −0.59 −0.04
26 10.30 5.88 0.57 0.00
27 1.00 0.66 0.67 0.00
28 1.96 2.81 1.43 0.00
29 0.48 0.59 1.23 1.15 6.96 6.05
30 2.07 7.39 3.58 0.00
Average 4.18 3.09 1.23 2.12 2.79 1.30
Sum 121.1 77.3 0.64 61.5 36.3 0.59
All treatments Exposure Cumulative effect Trend
182.6 113.6 0.62
Analysis of weight trends from 30 obese women of black African origin. Trend was calculated by linear regression of BMI against time over the period of treatment
exposure, excluding perinatal periods. Cumulative effect is the time-trend product. Average represents unweighted average of all episodes (*except #22, where
almost the whole weight graph was perinatal). Sum represents the cumulative of all episodes and trend in this row is the sum cumulative effect divided by the
cumulative exposure, i.e., a weighted average.
and some, obese pre-treatment, remained obese (7/30). The
average weight trend over 183 person-years of follow-up was
+0.62 kg/m2 year (Table 1). Rates were similar in patients on
NNRTI- and PI-based regimens (means 0.64 and 0.59 kg/m2 year,
respectively; P = 0.89; Table 1).
CURRENT NUTRITIONAL DEMOGRAPHICS OF HIV-CLINIC ATTENDERS
Since sequential one-month audits included only limited num-
bers of subjects, whole-year audits were performed in 2010–2011
and 2011–2012. As expected from the substantial overlap between
cohorts (977 patients in both), results were similar. Results from
the most recent cohort only are therefore presented including
1,031 subjects with median age 44 (range 19–83). Although over-
all similar numbers of men and women were included, more men
were white Caucasian (314/599, 52%), whilst most women (84%)
were of black African origin (363/432, including patients of black
African extraction but more-recent Caribbean origin) (Table 2).
Median CD4 was 500 cells/uL and 73% had an undetectable viral
load.
Assessment of BMI (Table 2) showed striking levels of obesity,
most prevalent in women of black African origin, of whom 49%
(177/363) were obese, with a further 32% (116/363) overweight.
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Table 2 | Distribution of BMI groups by gender and race among clinic attenders 2011–2012.
Malnourished Underweight Normal Overweight Obese Total % of cohort
by gender
<18.5 18.5–20 20–25 25–30 >30
n % n % n % n % n % n
Women
Asian 0 0 0 0 2 33 3 50 1 17 6 1
Black African 2 1 7 2 55 17 108 33 158 48 330 76
Black Caribbean 0 0 0 0 5 19 6 22 16 59 27 6
Black Other 0 0 0 0 1 17 2 33 3 50 6 1
Chinese/Asian Other 1 11 3 33 2 22 1 11 2 22 9 2
White Caucasian 2 4 6 13 14 30 14 30 10 22 46 11
Other/mixed race 1 13 2 25 2 25 1 13 2 25 8 2
Total women 6 1 18 4 81 19 135 31 192 44 432
Men
Asian 0 0 1 7 7 47 6 40 1 7 15 3
Black African 0 0 4 2 47 28 80 47 39 23 170 28
Black Caribbean 0 0 2 4 25 53 12 26 8 17 47 8
Black Other 1 9 0 0 4 36 3 27 3 27 11 2
Chinese/Asian Other 0 0 1 6 12 75 2 13 1 6 16 3
White Caucasian 4 1 10 3 147 47 113 36 40 13 314 52
Other/mixed race 0 0 5 19 13 50 7 27 1 4 26 4
Total men 5 1 23 4 255 43 223 37 93 16 599
All 11 1 41 4 336 33 358 35 285 28 1031
Number (n) and percentage (%) of HIV-clinic attenders within each BMI category for each defined major ethnic group. “White Caucasian” subjects were mostly of
Western European origin.
For females, black ethnicity gave a relative risk (RR) for obesity of
2.2 (95% confidence interval 1.4–3.6; P < 0.0001). In males, obe-
sity was also associated with black ethnicity, 22% being obese (RR
1.9, 1.3–2.7; P = 0.001), although numbers were smaller (50/228).
Conversely, wasting was uncommon in any sub-population; only
11/1,031 (1%) were wasted, and 52/1031 (5%) had a BMI of
<20 kg/m2.
Having demonstrated a significant trend to obesity, predomi-
nantly affecting Black African women, we generated five possible
explanatory hypotheses (framed as questions):
HYPOTHESIS 1: IS OBESITY IN AFRICANWOMEN AN EFFECT OF cART?
Interviews in the subgroup of 50 women from sub-Saharan
Africa [principally Uganda (16) and Zimbabwe (10)] revealed
that 48% felt their weight-gain was linked to their therapy
(39% “definite” and 9% “probable”). However, the observed
year-on-year increase in obesity was not associated with an
increased proportion of patients receiving cART; 86% in the
2011–2012 cohort, compared with 83% in 2001. (Similar val-
ues pertained at intermediate 3-year reviews: 75, 86, and 92%
in 2004, 2007, and 2010 respectively.) Furthermore, in the 2011–
2012 cohort, there was no difference between the mean BMI
of those on treatment and those not (27.5± 5.4 kg/m2, n= 884
versus 26.9± 5.2, n= 147, P = 0.21). Finally, there was no asso-
ciation between duration of cART and BMI in simple linear
regression analysis (r = 0.020, P = 0.59, n= 884). These data
do not therefore support a direct link between obesity and
cART.
HYPOTHESIS 2: IS OBESITY THE CONSEQUENCE OF CONCOMITANT
CLINICAL FACTORS?
In order to test this hypothesis, we performed stepwise multiple
linear regression analyses relating clinically plausible predictors
(age, gender, ethnicity, current smoking status, time since diagno-
sis, duration of cART, current viral load and CD4 count, gluco-
corticoid use, alcohol intake, diabetes mellitus, and hepatitis C)
to current BMI for both recent whole-year reviews (analyzed
separately as per section “Materials and Methods”). Very strong
associations were found between BMI and gender, black African
ethnicity, and smoking history (negatively) (Table 3). Age, CD4
count, and glucocorticoid use also emerged as important pos-
itive correlates. Duration of cART (taken as a linear variable)
made a weak, but negative, contribution in the latter cohort
(P = 0.013), and only after “time since diagnosis” was excluded
from the model; the two are clearly collinear. Time since diag-
nosis, viral load, ethanol excess, diabetes, and hepatitis C did not
add predictive power to the model. Route of exposure was con-
sidered but excluded because of collinearity. Gender and ethnicity
thus emerge as the strongest predictors of BMI, whilst smoking
reduces BMI.
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Table 3 | Potential predictors or weight gain; correlates of high BMI.
Factors Units n (%) or median (IQR) P Coeff r
2010–2011 Cohort
Model fit 1,166 <0.001 0.422
Female gender F =1 492 (42%) <0.001 +2.07 0.291
Black African ethnicity BA=1 691 (59%) <0.001 +1.73 0.290
Smoking Yes=1 265 (24%) <0.001 −2.14 0.297
CD4 count Cells/uL 500 (356, 678) <0.001 +0.0025 0.113
Age Years 43 (37, 49) <0.001 +0.068 0.099
Not in model* Rank
Duration cART Years 5.9 (2.7, 9.6) NS 3
Time since diagnosis Years 6.6 (3.2, 11.5) NS 2
Viral load Copies/ml 0 (0, 56) 73% ND NS 1
2011–2012 Cohort
Model fit 1,031 <0.001 0.495
Female gender F =1 432 (42%) <0.001 +2.85 0.314
Black African ethnicity BA=1 591 (57%) <0.001 +2.07 0.328
Smoking Yes=1 216 (24%) <0.001 −1.80 0.272
CD4 count Cells/uL 500 (380, 706) 0.039 +0.0019 0.109
Age Years 44 (38, 50) <0.001 +0.0808 0.075
Glucocorticoid use Yes=1 72 (7.1%) 0.024 +1.85 0.092
Duration cART Years 6.8 (3.6, 10.6) 0.002 −0.0004 0.020
Not in model* Rank
History of alcohol excess 0–3 1 (0, 1) NS 4
Time since diagnosis Years 7.7 (4.1, 12.3) NS 3
Diabetes mellitus Yes=1 47 (4.6%) NS 2
Hepatitis C Ab+=1 36 (4.0%) NS 1
Data are from both 2010–2011 and 2011–2012 cohorts (n=1,166 and 1,031, respectively; 977 subjects participated in both reviews). P values represent probability from
backward stepwise multiple linear regression model after elimination of non-contributory variables, listed in reverse order of removal from the model (*P< 0.05); route
of exposure was removed from the model a priori because of collinearity with gender and ethnicity. r values are from simple linear regression. Continuous variables
are shown as median (first, third quartile); alcohol excess was graded 0–3 (none, occasional, moderate, heavy); dichotomous categorical values were attributed binary
values (0 and 1) and are shown as number with attribute (% of recorded values).
HYPOTHESIS 3: IS OBESITY DRIVEN BY AN UNDERESTIMATION OF
WEIGHT?
Since it has been argued that weight perception differs in women
of African origin (28), we investigated the contribution of body-
weight perception to obesity in the subgroup of 50 African women.
Most were first-generation immigrants (median duration in the
UK 10 years), mostly (86%) from urban areas. Mean age was
40 years (range 20–60). Weight perception was explored using
three complementary modalities. First, using weight in kilograms,
subjects expressed a mean value for “usual” weight close to their
current weight (Figure 2A, shown normalized to BMI). “Ideal”
weights, however, differed between groups, correlating positively
with BMI group (r = 0.70, P < 0.0001; Figure 2A). Thus, more
obese subjects identified “ideal” body weights in the overweight
range according to WHO criteria (mean BMI for ideal weights:
29.1 kg/m2). These values were significantly higher than the“ideal”
values given by normal-weight women (23.0 kg/m2; P < 0.0001,
one-way ANOVA).
Verbal descriptors yielded a similar pattern. Subjects usually
described themselves with words corresponding to lower nutri-
tional status categories than their WHO BMI category (Table 4).
For example, 40% of obese subjects described themselves as “nor-
mal” weight, and 33% as “overweight”, whilst 47% of overweight
patients used the “normal” designation.
Third, when body shape perception was analyzed using silhou-
ettes corresponding to known BMI values [Series A (39)], obese
subjects dramatically underestimated their current level of adipos-
ity, identifying “current” body shape silhouettes corresponding to
a mean BMI of 26.2 kg/m2, whereas their true mean BMI was
35.0 kg/m2 (p= 0.0002, Wilcoxon signed rank test). When asked
about “ideal” body shape, both overweight and obese groups iden-
tified shapes less obese than their identified current shape with
both silhouette series (Figures 2B,C; P < 0.01 by Wilcoxon signed
rank test) but more obese subjects selected fatter“ideal”silhouettes
than thinner subjects [Figure 2B (Series A), r = 0.33, P = 0.02;
Figure 2C (Series B), r = 0.34, P = 0.02, Spearman]. The “ideal
shape” selected by obese subjects corresponded to a mean BMI
of 23 kg/m2, much less than their “ideal weight” (29.1 kg/m2),
demonstrating a significant perceptual gap between body weight
and body shape.
The difference between current shape and ideal shape is cus-
tomarily expressed as a “discrepancy score” (DS,= current – ideal
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FIGURE 2 | Relationship of perceived and ideal body size to current
nutritional status. (A) Perceived body weight: True (filled triangles, dashed
line), usual (filled circles), and ideal (open squares) body weight, expressed
in kilograms (normalized to BMI) of patients according to current nutritional
status category. “True” represents measured values, and “Usual” and
“Ideal” were derived from questionnaire responses. (B) Perceived body
shape from silhouettes corresponding to known BMI values (Series A)
compared to true BMI (filled triangles). Data are shown for perceived
(Continued)
FIGURE 2 | Continued
“current” shape (filled circles) and “ideal” shape (open squares).
(C) Perceived body shape from numbered silhouettes (Series B) expressed
as “current” shape (filled circles) and “ideal” shape (open squares).
(D) Subjects’ happiness with current body-weight scored from 1 to 5 (1,
very unhappy; 2, unhappy; 3, not bothered; 4, happy; 5, very happy)
according to current BMI category. All data shown are means± 1 SEM.
shape) (41, 42), which can be taken as a surrogate marker for
the drive to lose weight. As expected, and as widely observed
in non-HIV populations, this score was greater in those with
higher BMI. The intercept-value (DS= 0) corresponding to a
threshold for body image dissatisfaction was 26.9 kg/m2 in this
cohort (Figure 3A), a value in the “overweight” range, inter-
mediate between published values for white urban Americans
(24.6 kg/m2) and African-Americans (29.3 kg/m2) (42). Similarly,
those with high DS scores identified themselves with fatter silhou-
ettes (Figure 3B), but their drive to lose weight appeared“blunted”
when compared to population-based normative data for Cau-
casians (41), each DS score corresponding to a silhouette about
one score fatter than controls.
Thus all three modalities yielded similar conclusions that more
obese women have heavier target weights but underestimate both
their current level of obesity and the gap between current and
“ideal” body weight, consistent with a reduced drive to lose
weight.
HYPOTHESIS 4: IS OBESITY ASSOCIATED WITH A DESIRE TO BE
“FATTER”?
Contrary to the hypothesis that African women are happy to be
more obese, increased BMI was associated with a reduction in
how happy subjects felt about their body weight, according to the
satisfaction score attributed (Figure 2D; r = 0.32, P = 0.02, Spear-
man). The normal BMI group scored highest for satisfaction, 8/13
(62%) describing themselves as“very happy”or“happy”with their
weight. In the obese group, only 4/14 (29%) responded with these
scores, whilst 9/14 (64%) stated they were “unhappy” or “very
unhappy” with their weight (P = 0.03 versus normal BMI group,
chi-squared). This dissatisfaction was unrelated to concerns about
cardiovascular risk; most women participating (35/50, 70%) were
unaware of other major cardiovascular risk factors.
HYPOTHESIS 5: IS OBESITY THE CONSEQUENCE OF NORMALIZATION
TO THE POPULATION OF ORIGIN?
An alternative hypothesis is that HIV-positive patients are sim-
ply “normalizing” to the nutritional demographics of their
background population. We therefore compared our observations
with the most recent comparable ethnically categorized data, the
“2004 Health Survey for England: Health of Ethnic Minorities”
(HSE) (38) which includes BMI data on 11,022 UK residents, 5,443
classified by ethnicity. Although this national survey reported high
obesity rates in black African women (38% BMI> 30 kg/m2, ver-
sus 23% in the general female population, with a further 31%
overweight), our obesity rates exceeded these values by about 10%
(Figure 4A). Conversely men in our HIV-positive cohort had lower
levels of obesity than the general population (Figure 4B). In men,
black African ethnicity did not appear to favor obesity, either in
www.frontiersin.org November 2014 | Volume 5 | Article 507 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
McCormick et al. Obesity in African women on cART
Table 4 | Descriptions used by subjects to describe body weight according to nutritional status by BMI category.
True BMI group Perceived body weight Totals
Wasted Underweight Normal Overweight Obese
n % n % n % n % n %
Wasted (BMI>18.5) 0 0 1 50 1 50 0 0 0 0 2
Underweight (BMI 18.5–20) 0 0 0 0 2 100 0 0 0 0 2
Normal (BMI 20–25) 0 0 1 8 8 67 3 25 0 0 12
Overweight (BMI 25–30) 0 0 1 5 9 47 8 42 1 5 19
Obese (BMI>30) 0 0 0 0 6 40 5 33 4 27 15
All 0 0 3 6 26 52 16 32 5 10 50
Responses from 50 black African women recruited consecutively from clinic attenders regardless of weight/BMI.
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FIGURE 3 | Discrepancy between current and ideal body shape from
body shape silhouettes. (A) Discrepancy (current minus ideal) silhouette
score groups, shown according to the corresponding current mean BMI for
that group (groups with scores 1 and 2 were small so were conflated),
showing higher discrepancy scores correspond to higher BMI’s (r =0.37,
intercept 26.9 kg/m2, P <0.01, n=47). (B) Filled squares: discrepancy
scores by current silhouette score where higher silhouette score indicates
greater adiposity (r =0.61, P <0.001, n=47). Comparison is made with
normative data (open diamonds) from a large Caucasian population
(n=16,728) (41).
our cohort (P = 0.56), or in HSE, where obesity rates in black
African men were lower than the general population (17 versus
22%) (38). It might be argued that data from 2004 do not represent
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FIGURE 4 | Comparison of nutritional demographics in HIV-clinic
attenders to the general population. Distribution between different
nutritional status groups for HIV-positive clinic attenders (solid bars) versus
the general population (open and hatched bars). (A) Men, general
population (open), black African men in general population (shaded),
HIV-positive Caucasian males (solid bars), and (B) women, general
population (open bars), black African women in general population (shaded),
HIV-positive black African women (solid bars). Comparative data (HSE),
expressed as percentage of each ethnic group, are from the Health Survey
of England (n=11,022; 5,443 classified by ethnic group, including 629 black
Africans) (38). Note, HSE data did not give subgroup data for white
Caucasian populations and were not subdivided at 20 kg/m2, so
“underweight” and “normal” weight clinic attenders have been conflated
to demonstrate comparable data.
a sufficiently contemporaneous comparator; however, more recent
national obesity data categorized by ethnicity could not be identi-
fied. In order to compensate for this time difference, we compared
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obesity rates in women in England of all ethnicities in 2004 with
those in 2011. Rates increased from 23 to 26% (43) suggesting that
time-trends in obesity in the general population, whilst increasing,
are unlikely to explain the increase prevalence of obesity seen in
our clinic cohort.
DISCUSSION
Our data strongly support the hypothesis that obesity is increasing
in prevalence among HIV-positive patients on treatment, consis-
tent with the paradigm that obesity is “. . .the latest epidemic”
among HIV-infected individuals (7, 8). In our clinic-population,
the effect was greatest among women of black African origin, 49%
of whom were obese in this study. By contrast, wasting was very
infrequent, although, of course, studying an outpatient cohort
inevitably excluded acutely unwell in-patients and non-attenders
in whom wasting may be more frequent.
We explored several plausible mechanistic hypotheses to
explain the increasing prevalence of obesity in this population.
Regression analysis identified gender, age and ethnicity as major
correlates of this effect, together with a high CD4 count. Smok-
ing was associated with lower BMI, as generally observed. Many
women attributed their weight gain to antiretroviral therapy and
individual weight-graphs (Figure S3 in Supplementary Material)
suggest that weight gain occurs concurrently and progressively
during successful treatment. However, this was not corroborated
by analysis of duration of cART and BMI (where a weak correla-
tion only emerged after adjusting for other parameters, and then
the effect was negative). Not all collinearity could be controlled
for; thus it is impossible to dissect duration of cART from era in
which cART was started in this fixed time point cohort.
Such observations raise the question as to whether the weight-
gain seen in this cohort [and others (2, 7, 8, 11, 12)] represents
“normal” obesity, or is a variant of “HALS” (10). Certainly there is
evidence that ethnicity alters the phenotypic expression of HALS,
white race predisposing to lipoatrophy rather than fat accumula-
tion (44). More detailed regional body composition data might
clarify this issue, but were not collected here. Although changes
in drug selection have resulted in a significantly reduced preva-
lence of HALS (6), our data suggest that weight-gain data should
be monitored assiduously as the cumulative exposure to current
agents increases and as new drugs are rolled out.
Gender and ethnicity are associated with obesity in the gen-
eral population and our data follow similar trends. However, our
findings suggest that the African women in this cohort have signif-
icantly “overshot” background levels of obesity (49 versus 38%),
suggesting that regression to the norm is not an adequate expla-
nation for the weight-gain seen in patients on treatment. The
difficulties finding comparator data have been highlighted and
it is hoped that future studies, such as further iterations of the
Health Survey of England, will include ethnicity-specific data.
This study clearly has several limitations. First, the population
studied has an implicit recruitment-bias toward those successfully
adhering to treatment. Second, the silhouettes, although widely
used and easy to understand, have coarse gradations, constrain-
ing choice, and are ethnically dependent; culturally relevant tools
being developed may be more appropriate (45). Silhouette assess-
ment represents a composite of both perceptual and attitudinal
elements; more sophisticated tools such as digital morphing may
allow additional insights (46). To test the nutritional-programing
hypothesis,we included questions relating current obesity to birth-
weight, but few respondents could answer these questions (data
not shown). Collection of detailed body composition and dietary
parameters would have enabled further hypothesis-testing. In
terms of generalizability, we recognize the wide genetic diver-
sity between different sub-Saharan African populations and the
even greater differences, both genetic and cultural, between sub-
Saharan and American-African populations, in whom European
ancestry may contribute to obesity; (47) these two groups cannot
be conflated into a single category. Reanalysis, excluding Caribbean
patients from the category “of-African-origin” did not affect our
results, so we believe our results describe a generalizable phe-
nomenon, consistent with observations in other populations (2,
7, 8, 11, 12).
Since the major factors associated with this phenomenon, eth-
nicity, age and gender, are not amenable to intervention, we sought
to identify factors which were. Exploring the contribution of body-
weight perception to obesity revealed four major themes. First,
obese black African HIV-positive women tended to underestimate
current levels of adiposity (this was true for all three modalities
tested: numerical weight, word descriptors and body shape sil-
houettes), similar to a South African cohort (48). Second, obese
subjects defined higher “ideal” weights than their thinner counter-
parts. Third, there was a disparity between weight and shape: obese
subjects tended to underestimate the weight loss (in kg) required
to achieve a certain body shape. Fourth, disparity scores, which
reflect the drive to lose weight, were lower in our population than
comparator Caucasian populations.
Thus perceptions of obesity/adiposity may tend to promote or
maintain weight-gain, but this is not the same as a desire to be
fatter; indeed we found the converse was true. Greater adiposity
was associated with lower, not higher, levels of satisfaction with
current weight; obese patients in this cohort wanted to be thinner
than their current weight. Fear of weight loss was not specifically
mentioned in interviews but over half of the women surveyed had
experienced profound prior illness-associated weight loss. Aware-
ness of cardiovascular risk was low among this group of women
and thus not a major motivator for weight loss; this may not be
inappropriate as the average predicted 10-year CVD risk (49) for
individuals in the obese group (including cholesterol and blood
pressure, recorded but not presented here) was only 1.6%.
In conclusion, obesity appears to be a major developing prob-
lem among HIV-positive people on treatment, especially women
of African origin. Although antiviral therapy was perceived as
a contributing factor, we found little evidence to support this
hypothesis. Rather we found evidence for a high target “ideal”
weight, less dissatisfaction with a larger body shape, and poor
awareness of cardiovascular risk in this cohort. These are impor-
tant factors because they may be amenable to intervention.
Although perceptions and attitudes may be difficult to influ-
ence, improved patient education and dietetic advice could seek
to increase awareness of the propensity to and the risks of obesity.
Even small changes may be worthwhile; in other settings (e.g. type-
2 diabetes), minor reductions in weight can dramatically improve
metabolic status (50).
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